Tetra Radar · FDA Approvals · Decision date

anitocabtagene autoleucel: FDA decision date

Gilead Sciences Inc (GILD) · 23 December 2026

Announced that the Biologics License Application for anito-cel in 4L+ R/R MM has been accepted by FDA, with a PDUFA target action date of December 23, 2026.

Source: 10-Q of 30 October 2026

The decision is pending.

Gilead Sciences Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.